Competition
The Problems with the Paramount–Warner Merger
Yale SOM’s Jeffrey Sonnenfeld, governance expert Nell Minow, and co-author Stephen Henriques argue that the proposed combination would illegally concentrate power in Hollywood, weaken labor markets, and carry mounting financial risks, even if it ultimately closes.
Three Questions: Prof. James Baron on Amazon’s New Minimum Wage
We asked Prof. James Baron, an expert in human resources and labor markets, what Amazon’s $15 minimum wage would mean for workers there and at other companies.
When Should Companies Share Information with Competitors?
A study by Yale SOM’s Tristan Botelho suggests that, under certain circumstances, companies could benefit from sharing detailed information with competitors.
Three Questions: Prof. David Bach on Doing Business with Saudi Arabia
Professor David Bach answers questions about how businesses should weigh the risks and reputational costs in how they respond to the disappearance of Saudi Arabian journalist Jamal Khashoggi.
Does Performance-Based Pay Improve Teaching?
Yale SOM economist Barbara Biasi studied what actually happened when some school districts in Wisconsin started paying partly based on effectiveness.
Can Trusted Brands Beat ‘Fake News’?
Time Inc.’s chief content officer sees “fake news” as an opportunity for trusted brands in journalism to re-emerge—if they can find a business model.
How Can Philanthropy Do More Good?
Aaron Dorfman of the National Committee for Responsive Philanthropy argues that foundations need to re-think their strategies and tactics.
Is Antitrust Enforcement Out of Date?
U.S. antitrust laws, Yale SOM’s Fiona Scott Morton says, were written when new technology meant “typewriters and buggy whips and bicycles.” She assembled a group of economists and legal scholars to examine areas in which enforcement is out of sync with a changing economy.
Do Companies Buy Competitors in Order to Shut Them Down?
A study co-authored by Yale SOM researchers Florian Ederer and Song Ma suggests that “killer acquisitions” by pharmaceutical companies are potentially limiting the number of new treatments available.
Is Your Sales Team Courting the Wrong Customers?
A group of Yale SOM researchers examined what kinds of sales incentives lead to profits, and whether longstanding relationships between salespeople and customers are always a good thing.
Are We In a New Nuclear Arms Race?
Yale SOM’s Paul Bracken, an expert on defense strategy, discusses the consequences of a return to a "great power rivalry."
